Bamlanivimab + Etesevimab Therapy Induces SARS-CoV-2 Immune Escape Mutations and Secondary Clinical Deterioration in COVID-19 Patients with B-cell Malignancies
Domains
Human health and pathologyOrigin | Publisher files allowed on an open archive |
---|
Origin | Publisher files allowed on an open archive |
---|
Aude Jary : Connect in order to contact the contributor
https://hal.sorbonne-universite.fr/hal-03793520
Submitted on : Friday, September 6, 2024-11:11:25 AM
Last modification on : Thursday, November 7, 2024-2:21:36 PM